Pfizer and German biotech firm BioNTech’s Monday announcement that their COVID-19 vaccine candidate has shown to be more than 90% effective in preliminary results from an ongoing trial is a much needed win in the fight against the pandemic. While significant challenges remain, we are likely now closer to the end of the pandemic than the beginning. … READ MORE >
vaccine
CHART OF THE DAY: The race to find a coronavirus vaccine
Scientists have been working at a blistering pace to shorten the vaccine development cycle from years to months in order to get a COVID-19 vaccine to market. With more than 190 such vaccines in development, there are several leading the pack. Here’s the latest on these efforts, as of Oct. 15. … READ MORE >
The search for a safe and effective coronavirus vaccine
Americans are tired of the pandemic and the economic, health and political fallout we have collectively experienced from it. While there may be disagreement about the best way to approach the pandemic, it is generally held that a safe, effective COVID-19 vaccine that can be manufactured and distributed at scale is a critical step toward economic recovery. … READ MORE >
More promise, more problems: Cyberattacks threaten life sciences companies researching COVID-19 vaccine
Picture this scenario: Researchers at a biotech company are working tirelessly on a potential coronavirus vaccine and planning to start a phase three clinical trial soon. This work results in more visibility for the company, and an influx of capital investment. But with that greater visibility and investment comes added … … READ MORE >
Trump administration identifies 5 companies for government support in vaccine effort
Drug developers, academic institutions and government agencies across the globe are investigating more than 100 potential vaccines for the coronavirus. The Trump administration on Wednesday identified a handful of organizations that it believes are the most likely to produce a viable vaccine candidate, The New York Times reported. This is … … READ MORE >
Advances in gene sequencing accelerate the response to coronavirus outbreak
Advances in analysis technology and gene sequencing have allowed for the genome of the coronavirus to be sequenced in less than a month after the first case of the virus was reported. … READ MORE >